Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / LANCL1 as the Key Immune Marker in Neuropathic Pain.

< BACK TO ARCHIVE


2022


Neural Plast


http://www.ncbi.nlm.nih.gov/pubmed/35510269?dopt=Abstract


2022

LANCL1 as the Key Immune Marker in Neuropathic Pain.

Authors

LANCL1 as the Key Immune Marker in Neuropathic Pain.
Shi Y, Zhang XF, Fang Q, Zhan H, Wang X, Huang X, Fan T, Liu W, Wu W
Neural Plast. 2022; 2022:9762244.
PMID: 35510269.

Abstract

This study is to explore key immune markers and changes of immune microenvironment in neuropathic pain (NeuP).
Read This Paper